Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/11/2019
SIETES contiene 92834 citas

 
 
 1 a 20 de 30 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Healy D, Mangin D. Clinical judgments, not algorithms, are key to patient safety. BMJ 2019;367:2 de octubre. [Ref.ID 103204]
2. Cita con resumen
Tracy DK. Gabapentinoids linked to new risks, including suicidal behaviour. BMJ 2019;365:12 de junio. [Ref.ID 103153]
4.Enlace a cita original Cita con resumen
Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry 2019;176:1 de junio. [Ref.ID 103133]
5.Enlace a cita original Cita con resumen
Gobbi G, Atkin T, Zytnski T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood. A systematic review and meta-analysis. JAMA Psychiatry 2019;76:13 de febrero. [Ref.ID 103030]
6. Cita con resumen
King MA. Pregabalin and gabapentin associated with depression and suicidal ideation. BMJ 2018;363:29 de noviembre. [Ref.ID 102862]
7. Cita con resumen
Anónimo. FDA approves elagolix for endometriosis pain. DIA Daily 2018:25 de julio. [Ref.ID 102722]
8.Enlace a cita original Cita con resumen
Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Mozley LH, Vandenberghe R, Mo Y, Michelson D. Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102593]
9.Enlace a cita original Cita con resumen
Healy D. Antidepressants and murder: justice denied. BMJ 2017;358:26 de septiembre. [Ref.ID 102086]
10. Cita con resumen
Morkem R, Williamson T, Patten S, Queenan JA, Wong ST, Manca D, Barber D. Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis. Pharmacoepidemiol Drug Saf 2017;26:1093-9. [Ref.ID 102065]
11. Cita con resumen
Anónimo. Finasteride: rare reports of depression and suicidal thoughts. Drug Safety Update 2017;10:2-3. [Ref.ID 101600]
12.Tiene citas relacionadas Cita con resumen
Anónimo. FDA staff reviewers split over brodalumab’s suicide risk. DIA Daily 2016:1. [Ref.ID 100494]
13. Cita con resumen
Wise J. Number of children given antidepressants is rising, study shows. BMJ 2016;352:i1457. [Ref.ID 100331]
14.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Author’s reply to Dubicka and colleagues and Stone. BMJ 2016;352:i915. [Ref.ID 100054]
15.Tiene citas relacionadas Cita con resumen
Dubicka B, Cole-King A, Reynolds S, Ramchandani P. Paper on suicidality and aggression during antidepressant treatment was flawed and the press release was misleading. BMJ 2016;352:i911. [Ref.ID 100053]
17.Tiene citas relacionadas Cita con resumen
Moncrieff J. Misrepresenting harms in antidepressant trials. BMJ 2016;352:i217. [Ref.ID 100033]
18. Cita con resumen
Anónimo. Amgen ends partnership with AstraZeneca due to safety concerns with drug. DIA Daily 2015:26 de mayo. [Ref.ID 99095]
19. Cita con resumen
Anónimo. Éfavirenz: suicides. Prescrire 2015;35:105. [Ref.ID 98917]
20. Cita con resumen
Miller M, Swanson SA, Azrael D, Pate V, Stürmer T. Antidepressants dose, age, and the risk of deliberate self-harm. JAMA Intern Med 2014;174:899-909. [Ref.ID 98254]
Seleccionar todas
 
 1 a 20 de 30 siguiente >>